A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases

HPB

Volumn 15, Issue 7, 2013, Pages 483-491

  Lam, Vincent W T ^a,b   Laurence, Jerome M ^a   Johnston, Emma ^a,b   Hollands, Michael J ^a,b   Pleass, Henry C C ^a,b   Richardson, Arthur J ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; DISEASE FREE SURVIVAL; GASTROINTESTINAL STROMAL TUMOR; HUMAN; LIVER FAILURE; LIVER RESECTION; LONG TERM SURVIVAL; LUNG EMBOLISM; MORBIDITY; NEUROENDOCRINE TUMOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PATIENT SELECTION; PERIOPERATIVE PERIOD; PORTAL VEIN EMBOLIZATION; REVIEW; SALIVARY GLAND CARCINOMA; SURGICAL APPROACH; SURGICAL MORTALITY; SURVIVAL; SYSTEMATIC REVIEW; TWO STAGE HEPATECTOMY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; COLORECTAL TUMOR; LIVER NEOPLASMS; MORTALITY; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR; SECONDARY; TIME; TREATMENT OUTCOME; VASCULARIZATION; LIVER TUMOR; METASTASIS; METHODOLOGY;

CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; EMBOLIZATION, THERAPEUTIC; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884214841     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00607.x     Document Type: Review

References (62)

1. Parkin DM, Bray F, Ferlay J, Pisani P. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
2. Steele GJ, Ravikumar TS. (1989) Resection of hepatic metastases from colorectal metastases: biologic perspectives. Ann Surg 210:127-138.
3. Van Cutsem E, Rivera F, Berry S, Kretzschmar A, Michael M, Dibartolomeo M et al. (2009) Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol 20:1842-1847.
4. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR et al. (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818-825; discussion 825-827.
5. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD et al. (2002) Trends in longterm survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759-766.
6. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. (2004) Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240:438-447; discussion 447-450.
7. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309-318; discussion 318-321.
8. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T et al. (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: longterm results. Ann Surg 231:487-499.
9. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P et al. (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Fran?aise de Chirurgie. Cancer 77:1254- 1262.
10. Rees M, Tekkis PP, Welsh FKS, O'Rourke T, John TG. (2008) Evaluation of longterm survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247:125-135.
11. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. (1995) Resection of colorectal liver metastases. World J Surg 19:59-71.
12. Adson MA. (1987) Resection of liver metastases - when is it worthwhile? World J Surg 11:511-520.
13. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D et al. (1996) Resection of non-resectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509-522.
14. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumours. Ann Surg 232:777-785.
15. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Third Symposium on Systematic Reviews: Beyond the Basics. Oxford, 3-5 July 2000.
16. National Health and Medical Research Council. (1999) A Guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines. Canberra, ACT: AusInfo.
17. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:1-34.
18. Tanaka K, Shimada H, Matsuo K, Ueda M, Endo I, Togo S. (2007) Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur J Surg Oncol 33:329- 335.
19. Pamecha V, Nedjat-Shokouhi B, Gurusamy K, Glantzounis GK, Sharma D, Davidson BR. (2008) Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolization and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases. Dig Surg 25:387-393.
20. Wicherts DA, Miller R, de Haas RJ, Bitsakou G, Vibert E, Veilhan L-A et al. (2008) Longterm results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 248:994-1005.
21. Tsai S, Marques HP, De Jong MC, Mira P, Ribeiro V, Choti MA et al. (2010) Two-stage strategy for patients with extensive bilateral colorectal liver metastases. HPB 12:262-269.
22. Bowers KA, O'Reilly D, Bond-Smith GE, Hutchins RR. (2011) Feasibility study of two-stage hepatectomy for bilobar liver metastases. Am J Surg 203:691-697.
23. Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C et al. (2011) High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 29:1083-1090.
24. Muratore A, Zimmitti G, Ribero D, Mellano A, Vigan? L, Capussotti L. (2011) Chemotherapy between the first and second stages of a twostage hepatectomy for colorectal liver metastases: should we routinely recommend it? Ann Surg Oncol 19:1310-1315.
25. Turrini O, Ewald J, Viret F, Sarran A, Goncalves A, Delpero JR. (2012) Two-stage hepatectomy: who will not jump over the second hurdle? Eur J Surg Oncol 38:266-273.
26. Tsim N, Healey AJ, Frampton AE, Habib NA, Bansi DS, Wasan H et al. (2011) Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key. Ann Surg Oncol 18:1939-1946.
27. Narita M, Oussoultzoglou E, Jaeck D, Fuchschuber P, Rosso E, Pessaux P et al. (2011) Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg 98:1463-1475.
28. Karoui M, Vigan? L, Goyer P, Ferrero A, Luciani A, Aglietta M et al. (2010) Combined first-stage hepatectomy and colorectal resection in a twostage hepatectomy strategy for bilobar synchronous liver metastases. Br J Surg 97:1354-1362.
29. Tanaka K, Kumamoto T, Nojiri K, Takeda K, Ichikawa Y, Endo I. (2012) Timing of two-stage liver resection during chemotherapy for otherwise unresectable colorectal metastases. World J Surg 36:1832-1841.
30. Togo S, Nagano Y, Masui H, Tanaka K, Miura Y, Morioka D et al. (2005) Two-stage hepatectomy for multiple bilobular liver metastases from colorectal cancer. Hepatogastroenterology 52:913-919.
31. Homayounfar K, Liersch T, Schuetze G, Niessner M, Goralczyk A, Meller J et al. (2008) Two-stage hepatectomy (R0) with portal vein ligation - towards curing patients with extended bilobular colorectal liver metastases. Int J Colorectal Dis 24:409-418.
32. Lygidakis NJ, Bhagat AD, Vrachnos P, Grigorakos L. (2007) Challenges in everyday surgical practice: synchronous bilobar hepatic colorectal metastases - newer multimodality approach. Hepatogastroenterology 54:1020-1024.
33. Lygidakis NJ, Singh G, Bardaxoglou E, Dedemadi G, Sgourakis G, Nestoridis J et al. (2004) Two-stage liver surgery for advanced liver metastasis synchronous with colorectal tumour. Hepatogastroenterology 51:413-418.
34. Lygidakis NJ, Vlachos L, Raptis S, Rassidakis G, Balaskas C, Sgourakis G et al. (1999) New frontiers in liver surgery. Two-stage liver surgery for the management of advanced metastatic liver disease. Hepatogastroenterology 46:2216-2228.
35. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ et al. (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343:905-914.
36. Chua TC, Liauw W, Chu F, Morris DL. (2012) Summary outcomes of two-stage resection for advanced colorectal liver metastases. J Surg Oncol (In Press).
37. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M et al. (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25:4575-4580.
38. Viganò L, Ferrero A, Lo Tesoriere R, Capussotti L. (2008) Liver surgery for colorectal metastases: results after 10 years of follow-up. Longterm survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 15:2458-2464.
39. Pulitanò C, Castillo F, Aldrighetti L, Bodingbauer M, Parks RW, Ferla G et al. (2010) What defines ?cure? after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB 12:244- 249.
40. Poston GJ, Figueras J, Giuliante F, Nuzzo G, Sobrero AF, Gigot JF et al. (2008) Urgent need for a new staging system in advanced colorectal cancer. J Clin Oncol 26:4828-4833.
41. Khatri VP, Petrelli NJ, Belghiti J. (2005) Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 23:8490-8499.
42. Elias D, Baton O, Sideris L, Boige V, Malka D, Liberale G et al. (2005) Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. J Surg Oncol 90:36-42.
43. Lam VWT, Spiro C, Laurence JM, Johnston E, Hollands MJ, Pleass HCC et al. (2012) A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases. Ann Surg Oncol 19:1292-1301.
44. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A et al. (2000) Resection of non-resectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231:480-486.
45. Mohammad WM, Martel G, Mimeault R, Fairfull-Smith RJ, Auer RC, Balaa FK. (2012) Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons. HPB 14:291-297.
46. Folprecht G, Gruenberger T, Bechstein WO, Raab R, Lordick F, Hartmann JT et al. (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximan: the CELIM randomized phase 2 trial. Lancet Oncol 11:38-47.
47. Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA. (2006) Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13:1261-1268.
48. Adam R, Miller R, Pitombo M, Wicherts DA, de Haas RJ, Bitsakou G et al. (2007) Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin N Am 16:525-536.
49. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J et al. (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947.
50. Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D et al. (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22:229-237.
51. Masi G, Loupakis F, Salvatore L, Fornaro L, Cremolini C, Cupini S et al. (2010) Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial. Lancet Oncol 11:845-852.
52. Khan AZ, Morris-Stiff G, Makuuchi M. (2009) Patterns of chemotherapyinduced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg 16:137-144.
53. Morris-Stiff G, Tan Y-M, Vauthey JN. (2008) Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol 34:609-614.
54. Vauthey JN, Abbott DE. (2012) Commentary on ?Feasibility study of two-stage hepatectomy for bilobar liver metastases?. Am J Surg 203:698-699.
55. Benoist S, Nordlinger B. (2009) The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 16:2385-2390.
56. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B et al. (2004) Tumour progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 240:1052-1061; discussion 1061-1064.
57. Blazer DG 3rd, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ et al. (2008) Pathologic response to preoperative chemotherapy: a new outcome endpoint after resection of hepatic colorectal metastases. J Clin Oncol 26:5344-5351.
58. Kollmar O, Corsten M, Scheuer C, Vollmar B, Schilling MK, Menger MD. (2010) Tumour growth following portal branch ligation in an experimental model of liver metastases. Br J Surg 97:917-926.
59. Meredith K, Haemmerich D, Qi C, Mahvi D. (2007) Hepatic resection but not radiofrequency ablation results in tumour growth and increased growth factor expression. Ann Surg 245:771-776.
60. Farges O, Belghiti J, Kianmanesh R, Regimbeau J-M, Santoro R, Vilgrain V et al. (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 237:208-217.
61. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. (1999) Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 28:1-9.
62. Bravata DM, Olkin I. (2001) Simple pooling versus combining in metaanalysis. Eval Health Prof 24:218-230.